Report highlights significant improvements in adolescent well-being in India
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
RHTC will address a long-standing healthcare access issue for all the local population
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Women of all ages will get round-the-clock access to comprehensive treatment
The newest facility has all the core specialties like Obstetrics and Gynaecology, Orthopaedics, Neurology, Cardiology, Paediatrics, General Surgery, and Urology
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali
Subscribe To Our Newsletter & Stay Updated
